Categories: News

United States Digital Health (Technology/Component) Markets Report 2022-2026 Featuring Apple, McKesson, Alphabet, Cisco Systems, Cerner, & Allscripts Healthcare Solutions

DUBLIN, April 20, 2022 /PRNewswire/ — The “US Digital Health Market (by Technology & Component): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering.

The U.S. digital health market is predicted to reach US$240.65 billion in 2026, progressing at a CAGR of 28.40%, over the period 2022-2026.

The factors such as increasing geriatric population, growing usage of mobile devices, surging prevalence of arthritis, hike in healthcare expenditure, expanding urbanization and mounting penetration of internet users would drive the growth of the market.

However, the market growth would be challenged by high capital cost and installations, lack of interoperability and data breach and security concerns.

A few notable trends include an upsurge in the number of healthcare apps, surging occurrence of chronic diseases, escalating penetration of electronic health record (EHR) systems and increasing importance of wearable devices.

The U.S. digital health market has been segmented on the basis of technology and component. In terms of technology, the U.S. digital health market can be bifurcated into mHealth, digital health systems, health analytics and telehealthcare. Whereas, the market can be split into services, hardware and software, on the basis of component.

The competitive landscape of the market, along with the company profiles of leading players (Apple Inc., McKesson Corporation, Alphabet Inc., Cisco Systems, Inc., Cerner Corporation and Allscripts Healthcare Solutions, Inc.) are also presented in detail.

Key Topics Covered:

1. Market Overview
1.1 Introduction
1.2 Global Evolution of Digital Health
1.3 Classification of Digital Health
1.4 Essential Components of Digital Health
1.5 Benefits of Digital Health Technologies
1.6 Technologies Involved in Digital Healthcare
1.7 Digital Health Tools

2. COVID-19 Impact
2.1 Demand Surge for Digital Health Solutions
2.2 Surging Adoption of Telemedicine
2.3 Rising Depression Rate

3. The U.S. Market Analysis
3.1 The U.S. Digital Health Market by Value
3.2 The U.S. Digital Health Market Forecast by Value
3.3 The U.S. Digital Health Market by Technology
3.3.1 The U.S. mHealth Digital Health Market by Value
3.3.2 The U.S. mHealth Digital Health Market Forecast by Value
3.3.3 The U.S. mHealth Digital Health Market by Services
3.3.4 The U.S. mHealth Digital Health Services Market by Value
3.3.5 The U.S. mHealth Digital Health Services Market Forecast by Value
3.3.6 The U.S. Digital Health Systems Market by Value
3.3.7 The U.S. Digital Health Systems Market Forecast by Value
3.3.8 The U.S. Health Analytics Market by Value
3.3.9 The U.S. Health Analytics Market Forecast by Value
3.3.10 The U.S. Tele Healthcare Market by Value
3.3.11 The U.S. Tele Healthcare Market Forecast by Value
3.4 The U.S. Digital Health Market by Component
3.4.1 The U.S. Digital Health Services Market by Value
3.4.2 The U.S. Digital Health Services Market Forecast by Value
3.4.3 The U.S. Digital Health Hardware Market by Value
3.4.4 The U.S. Digital Health Hardware Market Forecast by Value
3.4.5 The U.S. Digital Health Software Market by Value
3.4.6 The U.S. Digital Health Software Market Forecast by Value

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Geriatric Population
4.1.2 Growing Usage of Mobile Devices
4.1.3 Surging Prevalence of Arthritis
4.1.4 Hike in Healthcare Expenditure
4.1.5 Expanding Urbanization
4.1.6 Surging Occurrence of Chronic Diseases
4.1.7 Mounting Penetration of Internet Users
4.2 Key Trends & Developments
4.2.1 Upsurge in the Number of Healthcare Apps
4.2.2 Escalating Penetration of Electronic Health Record (EHR) Systems
4.2.3 Increasing Importance of Wearable Devices
4.2.4 Rising Integration with Artificial Intelligence
4.2.5 Surging Adoption of SaaS Applications
4.2.6 Supportive Government Initiatives
4.3 Challenges
4.3.1 High Capital Cost and Installations
4.3.2 Lack of Interoperability
4.3.3 Data Breach and Security Concerns

5. Company Profiles

  • Apple Inc.
  • McKesson Corporation
  • Alphabet Inc.
  • Cisco Systems, Inc.
  • Cerner Corporation
  • Allscripts Healthcare Solutions, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/9lkg95

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/united-states-digital-health-technologycomponent-markets-report-2022-2026-featuring-apple-mckesson-alphabet-cisco-systems-cerner–allscripts-healthcare-solutions-301529048.html

SOURCE Research and Markets

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago